Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 22, 2016

Primary Completion Date

November 28, 2024

Study Completion Date

November 28, 2024

Conditions
Skull Base ChordomaVertebral Chordoma
Interventions
PROCEDURE

Surgery

"The operative approach and operating time will be performed according to neurosurgical practices (for head and neck) or surgical orthopaedic team (for sacrum) depending on the location, the extension and the relationship of the lesion to critical structures.~The surgery can be macroscopically complete or incomplete."

RADIATION

Protontherapy

Radiotherapy will be done with the Cyclotron, for a total dose of 78 Gray Relative Biological Effective (Gy RBE) - 70 Gy RBE to the tumor bed and macroscopic volume and 8 Gy RBE to the the hypoxic component volume, delivered in 39 fractions spread over 67 days.

DRUG

18F FAZA

FAZA PET/CT, in order to target the hypoxic zones

Trial Locations (1)

92210

Institut Curie - Hôpital René Huguenin, Saint-Cloud

All Listed Sponsors
lead

Institut Curie

OTHER

NCT02802969 - Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers | Biotech Hunter | Biotech Hunter